Ha130 Hemoperfusion Cartridge
Ha130 Hemoperfusion Cartridge
Ha130 Hemoperfusion Cartridge
[Product Description]
HA130 resin hemoperfusion cartridge is of relatively specific recognition and adsorption capacity to the macromolecular uremic toxins resulting from long-term hemodialysis and hemofiltration in blood of end-stage renal disease (ESRD) patients.
In clinic, HD+HP treatment by association of hemodialysis (HD) & hemoperfusion(HP) could clear various uremic toxins in ESRD patients, decrease morbidity of complications in long-term and short-term, prolong life span and improve life quality. The product is hereinafter named as hemoperfusion cartridge for short.
[Product Application]
1. Product purpose: the product could adsorb uremic toxins such as parathyrin, β2-microglobulin, leptin, oxidation protein products, end-stage glycosylation products, homocysteine, feritin, angiotensin, interleukin 1, 6 etc. in hemodialysis patients.
2. Application of patients: the product is applicable to hemodialysis patients, and HP+HD joint treatment which could prevent and improve long-term hemodialysis complications such as renal osteopathy, refractory skin pruritus, peripheral neuropathy, cardiovascular disease, refractory hypertension, nephro-encephalopathy, malnutrition etc.
HA130 resin hemoperfusion cartridge is of relatively specific recognition and adsorption capacity to the macromolecular uremic toxins resulting from long-term hemodialysis and hemofiltration in blood of end-stage renal disease (ESRD) patients.
In clinic, HD+HP treatment by association of hemodialysis (HD) & hemoperfusion(HP) could clear various uremic toxins in ESRD patients, decrease morbidity of complications in long-term and short-term, prolong life span and improve life quality. The product is hereinafter named as hemoperfusion cartridge for short.
[Product Application]
1. Product purpose: the product could adsorb uremic toxins such as parathyrin, β2-microglobulin, leptin, oxidation protein products, end-stage glycosylation products, homocysteine, feritin, angiotensin, interleukin 1, 6 etc. in hemodialysis patients.
2. Application of patients: the product is applicable to hemodialysis patients, and HP+HD joint treatment which could prevent and improve long-term hemodialysis complications such as renal osteopathy, refractory skin pruritus, peripheral neuropathy, cardiovascular disease, refractory hypertension, nephro-encephalopathy, malnutrition etc.
- Place of Origin:
- China
- Brand:
- Jafron